Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.92 USD | +0.19% | +3.74% | -44.74% |
09/05 | Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.74% | 79Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.11% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Morgan Stanley Cuts Price Target on Disc Medicine to $40 From $75, Says Bitopertin Trial's Missed Secondary Endpoint Increases Uncertainty on Regulatory Path; Equalweight Kept